On Wednesday, June 2, 2021, Group B Strep Support (GBSS) is holding their one-day virtual conference, Group B Strep in Pregnancy & Babies. There will be multiple speakers at this event, including Carol J. Baker, Professor of Pediatrics at McGovern Medical School at the University of Texas and Sabin Gold Medal winner; Professor Androulla Efstratiou from the Imperial College in London and Director of WHO Global Collaborating Centre for Diptheria & Streptococcal Infections; and Professor Anne Mackie, Director of Screening for Public Health England.
Conference chairs for this event are Edward Morris, President of the Royal College of Obstetricians and Gynaecologists and Chair of Trustees for GBSS; and Kathryn Gutteridge, President of the Royal College of Midwives and GBSS Trustee.
Sponsorship Information
LabReady is proud to be a silver sponsor for this event, joining Pfizer, Cepheid, and Leigh Day.
Group B Strep’s Impact
Group B Strep (GBS) is a leading cause of neonatal infection – including sepsis, pneumonia and meningitis – in the UK and worldwide. Illness and death caused by this bacteria can be prevented through testing and antibiotics. At this conference, experts from around the world come together to discuss GBS prevention through policy, testing and antibiotic usage as well as current progress toward a GBS vaccine.
About LabReady
The first step in preventing illness or death caused by GBS is testing. LabReady has developed an improved specimen transport system for GBS samples as they travel from doctor to laboratory. These self-contained units regulate specimen temperature to maintain an unbroken cold chain and provide a nutritive solution to facilitate faster testing and diagnosis.
To speak with a LabReady representative, email us: https://www.labready.com/#modalPatients.
